Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Glioma resection and tumor recurrence: back to Semmelweis.

Ratel D, van der Sanden B, Wion D.

Neuro Oncol. 2016 Dec;18(12):1688-1689. Epub 2016 Oct 7. No abstract available.

2.

Response to "Glioma resection and tumor recurrence: back to Semmelweis".

Menei P, Clavreul A, Lemée JM.

Neuro Oncol. 2016 Dec;18(12):1689. Epub 2016 Oct 7. No abstract available.

3.

Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Okolie O, Bago JR, Schmid RS, Irvin DM, Bash RE, Miller CR, Hingtgen SD.

Neuro Oncol. 2016 Dec;18(12):1622-1633. Epub 2016 Jun 13.

4.

The brain tissue response to surgical injury and its possible contribution to glioma recurrence.

Hamard L, Ratel D, Selek L, Berger F, van der Sanden B, Wion D.

J Neurooncol. 2016 May;128(1):1-8. doi: 10.1007/s11060-016-2096-y. Epub 2016 Mar 9. Review.

PMID:
26961772
5.

Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.

Shimato S, Nishizawa T, Ohshima T, Imai T, Goto S, Yamamoto T, Kato K.

World Neurosurg. 2016 Jun;90:340-347. doi: 10.1016/j.wneu.2016.02.102. Epub 2016 Mar 4.

PMID:
26960286
6.

CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.

Tang W, Wang X, Chen Y, Zhang J, Chen Y, Lin Z.

Pathol Biol (Paris). 2015 Sep;63(4-5):190-8. doi: 10.1016/j.patbio.2015.07.002. Epub 2015 Aug 14.

PMID:
26277915
7.

Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence.

Fierstra J, van Niftrik B, Piccirelli M, Burkhardt JK, Pangalu A, Kocian R, Valavanis A, Weller M, Regli L, Bozinov O.

Magn Reson Imaging. 2016 Jul;34(6):803-808. doi: 10.1016/j.mri.2016.02.003. Epub 2016 Mar 8.

9.

Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.

Preul MC, Leblanc R, Caramanos Z, Kasrai R, Narayanan S, Arnold DL.

Can J Neurol Sci. 1998 Feb;25(1):13-22.

PMID:
9532276
10.

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Kreth FW, Warnke PC, Ostertag CB.

Cancer. 1995 Jun 1;75(11):2785-7. No abstract available.

PMID:
7743491
11.

Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.

Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos AD, Argyropoulou MI.

Magn Reson Imaging. 2014 Sep;32(7):854-9. doi: 10.1016/j.mri.2014.04.013. Epub 2014 Apr 24.

PMID:
24848292
12.

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W.

J Neurooncol. 2015 Sep;124(2):215-21. doi: 10.1007/s11060-015-1825-y. Epub 2015 May 30.

PMID:
26024653
13.

Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.

Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 Jan;112(1):10-7. doi: 10.3171/2008.10.JNS08608.

PMID:
19361270
14.

DNA hypomethylation of CD133 promoter is associated with recurrent glioma.

Sun B, Wan Z, Shen J, Ni L, Chen J, Cui M, Ni H, Shi W, Shi J.

Oncol Rep. 2016 Aug;36(2):1062-8. doi: 10.3892/or.2016.4880. Epub 2016 Jun 16.

PMID:
27374817
15.

In reply: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?

Hervey-Jumper SL, Berger MS.

Neurosurgery. 2015 Apr;76(4):E497. doi: 10.1227/NEU.0000000000000667. No abstract available.

PMID:
25635894
16.

Letter: Reoperation for recurrent high-grade glioma: does tumor genetics play a role?

Zhao X, Bai HX, Zou Y, Yang L.

Neurosurgery. 2015 Apr;76(4):E496-7. doi: 10.1227/NEU.0000000000000666. No abstract available.

PMID:
25635893
17.

Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.

McLendon RE, Akabani G, Friedman HS, Reardon DA, Cleveland L, Cokgor I, Herndon JE 2nd, Wikstrand C, Boulton ST, Friedman AH, Bigner DD, Zalutsky MR.

Nucl Med Biol. 2007 May;34(4):405-13. Epub 2007 Mar 30.

18.

Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.

Heßelmann V, Mager AK, Goetz C, Detsch O, Theisgen HK, Friese M, Schwindt W, Gottschalk J, Kremer P.

Rofo. 2017 Jun;189(6):519-526. doi: 10.1055/s-0043-106189. Epub 2017 Jun 7.

19.

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Berger MS, Deliganis AV, Dobbins J, Keles GE.

Cancer. 1994 Sep 15;74(6):1784-91.

PMID:
8082081
20.

Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance.

Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM.

Cancer. 2005 Mar 15;103(6):1227-33.

Supplemental Content

Support Center